EPS Diluted (TTM) Chart

View EPS Diluted (TTM) for PGEN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (TTM) Chart
Start Trial

Historical EPS Diluted (TTM) Data

View and export this data back to 2012. Start Trial.
Date Value
June 30, 2026 -1.100
March 31, 2026 -1.238
December 31, 2025 -1.400
September 30, 2025 -1.401
June 30, 2025 -0.4285
March 31, 2025 -0.5716
December 31, 2024 -0.4825
September 30, 2024 -0.5479
June 30, 2024 -0.5406
March 31, 2024 -0.3895
December 31, 2023 -0.3932
September 30, 2023 -0.3669
June 30, 2023 -0.3238
March 31, 2023 -0.3299
December 31, 2022 -0.3274
September 30, 2022 -0.342
June 30, 2022 -0.4549
March 31, 2022 -0.4676
December 31, 2021 -0.4607
September 30, 2021 -0.5734
June 30, 2021 -0.6023
March 31, 2021 -0.7658
December 31, 2020 -1.030
September 30, 2020 -1.886
June 30, 2020 -2.055
Date Value
March 31, 2020 -2.042
December 31, 2019 -2.086
September 30, 2019 -3.584
June 30, 2019 -3.68
March 31, 2019 -3.938
December 31, 2018 -3.871
September 30, 2018 -1.513
June 30, 2018 -1.40
March 31, 2018 -1.05
December 31, 2017 -0.98
September 30, 2017 -1.12
June 30, 2017 -1.03
March 31, 2017 -1.29
December 31, 2016 -1.58
September 30, 2016 -1.49
June 30, 2016 -1.59
March 31, 2016 -1.54
December 31, 2015 -0.74
September 30, 2015 -0.28
June 30, 2015 -0.47
March 31, 2015 -0.63
December 31, 2014 -0.84
September 30, 2014 -1.15
June 30, 2014 -0.47
March 31, 2014 -2.40

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Geron Corp. -0.1046
Neurocrine Biosciences, Inc. 6.826
Elicio Therapeutics, Inc. -2.114
Agenus, Inc. 2.651
Amgen, Inc. 16.10